NFE2L2 and alcoholic liver diseases: In alcoholic liver disease, increasing the deacetylase activity of SIRT6 reduces the level of acetylated nuclear factor erythroid 2-related factor 2 (NRF2), thereby increasing the stability of NRF2, and thus attenuating hepatocyte damage and oxidative stress 36.